荟萃分析
医学
不利影响
梅德林
重症监护医学
内科学
化学
生物化学
作者
Ronald Man Yeung Wong,Pui Yan Wong,Chaoran Liu,Hubert Wong,M.K. Fong,Ning Zhang,Wing‐Hoi Cheung,Sheung Wai Law
标识
DOI:10.1016/j.jot.2024.07.011
摘要
Romosozumab is a novel monoclonal antibody that binds to sclerostin, and has dual effects of increasing bone formation and decreasing bone resorption, giving it a unique mechanism of action. The objective of this study was to perform a systematic review and meta-analysis based on existing worldwide data on treatment effects and safety of romosozumab in randomized controlled trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI